NCT05445882 2024-04-02N-803 Alone or in Combination With BN-Brachyury Vaccine or Bintrafusp Alfa (M7824) for Participants With Castration Resistant Prostate CancerNational Institutes of Health Clinical Center (CC)Phase 2 Withdrawn